Sonata Capital Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Sonata Capital Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$277K	Buy	1,750 +150	+9%	+$20.3K	0.09%	115
2026 Q1	$204K	Buy	+1,600	New	+$200K	0.08%	123
2021 Q4	–	Sell	-2,300	Closed	-$289K	–	127
2021 Q3	$289K	Hold	2,300	–	–	0.13%	102
2021 Q2	$311K	Hold	2,300	–	–	0.14%	103
2021 Q1	$312K	Buy	2,300 +200	+10%	+$29.9K	0.15%	102
2020 Q4	$296K	Hold	2,100	–	–	0.15%	100
2020 Q3	$234K	Buy	+2,100	New	+$235K	0.14%	106
2017 Q4	–	Sell	-3,200	Closed	-$277K	–	103
2017 Q3	$277K	Sell	3,200 -250	-7%	-$20K	0.21%	92
2017 Q2	$266K	Hold	3,450	–	–	0.2%	91
2017 Q1	$239K	Sell	3,450 -750	-18%	-$50.4K	0.18%	92
2016 Q4	$249K	Sell	4,200 -1,150	-21%	-$71K	0.19%	90
2016 Q3	$355K	Hold	5,350	–	–	0.29%	74
2016 Q2	$289K	Hold	5,350	–	–	0.25%	80
2016 Q1	$276K	Sell	5,350 -2,450	-31%	-$127K	0.24%	82
2015 Q4	$548K	Buy	7,800 +1,050	+16%	+$71.6K	0.48%	51
2015 Q3	$420K	Buy	6,750 +2,250	+50%	+$177K	0.39%	62
2015 Q2	$378K	Buy	+4,500	New	+$350K	0.32%	73

Other funds holding XBI

MSR

Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

WAM

Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

RFM

Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return

NHFG

New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return

RAM

Riggs Asset Management Dallas, Pennsylvania $560M AUM 64.94% 1-Year Est. Return

Sonata Capital Group's XBI Position: Q2 2026 in Review

Sonata Capital Group increased its State Street SPDR S&P Biotech ETF (XBI) stake by 9.4% in Q2 2026, buying an estimated $20.3K and bringing the position to 1,750 shares worth $277K. The position accounts for 0.09% of the portfolio, ranked #115.

Sonata Capital Group first reported a position in XBI in Q2 2015 and has held it in 17 quarters since. The position peaked at $548K in Q4 2015. 393 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Sonata Capital Group held 1,750 shares of State Street SPDR S&P Biotech ETF worth $277K as of Q2 2026.
Sonata Capital Group bought 150 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $20.3K.
State Street SPDR S&P Biotech ETF made up 0.09% of Sonata Capital Group's portfolio in Q2 2026, its #115 holding.
Sonata Capital Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2015 and has held it in 17 quarters since.
Sonata Capital Group's State Street SPDR S&P Biotech ETF position peaked at $548K in Q4 2015.
393 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Sonata Capital Group's 13F filing for Q2 2026, filed 24 Jul 2026.